Fox Chase Cancer Center News

PHILADELPHIA (October 21, 2022)—Shelly Hayes, MD, director of Fox Chase Cancer Center Buckingham and associate professor in the Department of Radiation Oncology, was recently presented with an inaugural Earth Angel Award during the 5th Annual Pine2Pink event in Doylestown.

PHILADELPHIA (October 21, 2022)—Fox Chase Cancer Center’s Andrea Porpiglia, MD, MSc, FACS, assistant professor in the Department of Surgical Oncology, was recently inducted as a fellow into the Philadelphia Academy of Surgery.

PHILADELPHIA (October 20, 2022)—A team of advanced practice providers in the Department of Hematology/Oncology at Fox Chase Cancer Center have received the 2021 Article of the Year Award from the Journal of the Advanced Practitioner in Oncology (JADPRO). This award is given to one article each year that demonstrates an exceptional contribution to the body of literature for oncology advanced practice.

PHILADELPHIA (October 18, 2022)—The development of a family of drugs known as Bruton tyrosine kinase inhibitors (BTKi) was a huge step forward in treating chronic lymphocytic leukemia and non-Hodgkin lymphoma.

PHILADELPHIA (October 17, 2022)—Fox Chase Cancer Center was recently awarded a grant for $6 million over the course of five years to develop a new Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT). The new National Cancer Institute (NCI) program was created to establish a pipeline for the discovery of new cancer-prevention agents.

PHILADELPHIA (October 10, 2022)— Fox Chase Cancer Center is pleased to announce the hiring of Charnita Zeigler-Johnson, PhD, MPH, as Associate Director of Community Outreach and Engagement (COE).

PHILADELPHIA (October 6, 2022)—The Department of Medicine at Fox Chase Cancer Center is pleased to announce the hiring of Joseph R. Triggs, MD, PhD, as an assistant professor in the Division of Gastroenterology.

PHILADELPHIA (September 27, 2022)—Researchers at Fox Chase Cancer Center have identified a new cellular pathway that plays a key role in causing melanoma to become invasive and hastening its spread.